Are Social Media Influencers Fracturing MAGA?
There's About to Be Some Prime GOP Betrayal on the SAVE Act
Jerry O'Connell Admitted Something to Bill Maher..and the HBO Host Couldn't Tolerate It
So, Based on These Remarks, Graham Platner Knew This Was a Nazi Tattoo,...
Hey, Dems, Even CNN Says Your Anti-Trump Talking Points on Operation Epic Fury...
Did You Miss the Trump White House Calling Out This CBS News Host?...
What If Iranians Don’t Want to Be ‘Free’?
It Looks Like the Israel Defense Force Just Eliminated the Basij Commander
Read Fairfax County School Board's Lame Statement on Illegal Alien Accused of Groping...
It Turns Out Zohran Mamdani Is a Just Another Autocratic Socialist
Gavin Newsom's Press Office Just Attacked Nick Shirley for Exposing California Fraud
The World Better Get Ready for the New Dark Ages
I'll Take a Side Order of Lies With That
Red Pens Did Me Good
No Off-Ramp: Dominating Full Spectrum Warfare Will End the Iranian Regime
Tipsheet

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order
AP Photo/Evan Vucci

President Trump signed an executive order on Monday ending current and future federal funding for gain-of-function research in certain countries, such as China and Iran.

Advertisement

The order seeks to protect Americans from this type of “dangerous” research and any lab accidents and biosecurity incidents that most likely caused the COVID-19 pandemic.

American innovation will not be impeded by the order, according to the White House, but it will increase the safety and security of biological research in the U.S.

  • For decades, policies overseeing gain-of-function research on pathogens, toxins, and potential pathogens have lacked adequate enforcement, transparency, and top-down oversight. Researchers have not acknowledged the legitimate potential for societal harms that this kind of research poses.
  • The Biden Administration allowed dangerous gain-of-function research with insufficient levels of oversight and actively approved Federal life-science research funding in China and other countries.
  • The 2024 United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential (“DURC/PEPP”) and the 2024 Framework for Nucleic Acid Synthesis Screening are the latest examples of inadequate policies that rely on self-reporting and fail to protect Americans from dangerous research practices.
  • This Order pauses research using infectious pathogens and toxins in the United States that may pose a danger to American citizens until a safer, more enforceable, and transparent policy governing such research can be developed and implemented. It directs the Director of the Office of Science and Technology Policy (OSTP) and the National Security Advisor (NSA) to work with funding agencies to develop such a policy within 120 days.
  • Unlike previous policies, this Order contains enforcement and reporting mechanisms that will strengthen oversight and discourage subjective interpretation of policies that researchers have used in the past to evade biosafety and biosecurity oversight. (White House)
Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement